MedPath

NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward

Conditions
Shortness of Breath
Acute Exacerbation
Registration Number
NCT00271128
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.

Detailed Description

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.

Patients will be consented and randomized to open or blinded NT-proBNP test performed within 90 minutes in a venous blood sample.

Evaluation of the ER diagnosis and final discharge diagnosis in admitted patients will be carried out in light of the NT-proBNP results.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. Acute shortness of breath of unknown etiology as presentation to the emergency room
  2. Possible acute exacerbation of known heart failure
Exclusion Criteria

None -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath